Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
13F holders, Q1 2026
Institutional positions in Cidara Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
CDTX is no longer listed, and 13F filings after Q4 2025 list far fewer holders. See Q4 2025
- Institutional holders
- 0
- −247 vs. Q4 2025
- Shares held
- 0
- −30.6M (−100.0%) vs. Q4 2025
- Total value
- $0
- −$6.76B (−100.0%) vs. Q4 2025
- New holders
- 0
- 0 more added
- Sold out
- 247
- 0 more reduced
8 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 255 | $7.36B |
| Q3 2025 | 173 | $3.11B |
| Q2 2025 | 109 | $1.26B |
| Q1 2025 | 46 | $205.9M |
| Q4 2024 | 40 | $183.6M |
| Q3 2024 | 27 | $35.6M |
| Q2 2024 | 26 | $16.9M |
| Q1 2024 | 50 | $20.3M |
| Q4 2023 | 51 | $18.4M |
| Q3 2023 | 52 | $22.7M |
| Q2 2023 | 52 | $29.7M |
| Q1 2023 | 54 | $34.4M |
| Q4 2022 | 42 | $20.2M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 46 | $13.3M |
| Q1 2022 | 44 | $25.2M |
| Q4 2021 | 53 | $39.5M |
| Q3 2021 | 50 | $42.1M |
| Q2 2021 | 55 | $40.5M |
| Q1 2021 | 62 | $56.6M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Cidara Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −1,224−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −1,199−100.0% | Sold out |
| Sterling Capital Management LLC | 0 | $0 | 0.00% | −1,139−100.0% | Sold out |
| Banco BTG Pactual S.A. | 0 | $0 | 0.00% | −1,136−100.0% | Sold out |
| Abel Hall, LLC | 0 | $0 | 0.00% | −1,069−100.0% | Sold out |
| Cora Capital Advisors LLC | 0 | $0 | 0.00% | −1,016−100.0% | Sold out |
| PenderFund Capital Management Ltd. | 0 | $0 | 0.00% | −900−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −635−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −616−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −578−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −474−100.0% | Sold out |
| KBC Group NV | 0 | $0 | 0.00% | −376−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −314−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −294−100.0% | Sold out |
| First Horizon Corp | 0 | $0 | 0.00% | −153−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −101−100.0% | Sold out |
| Danske Bank A/S | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −63−100.0% | Sold out |
| Wolff Wiese Magana LLC | 0 | $0 | 0.00% | −58−100.0% | Sold out |
| Essential Partners LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| WPG Advisers, LLC | 0 | $0 | 0.00% | −48−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −48−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −47−100.0% | Sold out |
| Vermillion & White Wealth Management Group, LLC | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| SHP Wealth Management | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Bell Investment Advisors, Inc | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Bare Financial Services, Inc | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| RHL Group, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| SJS Investment Consulting Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Keating Financial Advisory Services, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| UBS Oconnor LLC | – | – | – | – | Not filed |
| Norges Bank | – | – | – | – | Not filed |
| Omni Event Management Ltd | – | – | – | – | Not filed |
| CIBC World Markets Corp | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |